Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1991
10/09/1991EP0450345A1 Indole derivatives
10/09/1991EP0450238A1 Novel compounds for the treatment of migraine
10/09/1991EP0450100A1 Physiologically active peptide
10/09/1991EP0449972A1 Triple stranded nucleic acid and methods of use
10/09/1991EP0449884A1 Derivatives of tetrapeptides as cck agonists
10/09/1991CN1055179A 8-sulfamy lmethylene-2-amino tetralins
10/08/1991US5055598 Benzopyran derivatives
10/08/1991US5055480 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
10/08/1991US5055476 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
10/08/1991US5055470 Method of treatment of ischemia in brain
10/08/1991US5055302 Nearsightedness
10/08/1991CA1290340C Process for the preparation of aryl-piperidine esters
10/08/1991CA1290333C 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, processes for the preparation thereof, agents containing same, and the use thereof
10/08/1991CA1290251C Spray dried acetaminophen
10/06/1991WO1991015451A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes
10/06/1991CA2079785A1 Derivatives of phenyl-cycloalkanes and cycloalkenes
10/06/1991CA2039541A1 Monoclonal antibodies to avermectins
10/04/1991CA2039507A1 Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states
10/03/1991WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus
10/03/1991WO1991014686A1 Azacyclic or azabicyclic compounds, their preparation and use
10/03/1991WO1991014455A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief
10/03/1991WO1991014443A1 A method for regulating neuron development and maintenance
10/03/1991WO1991014438A1 Chimeric antibodies with receptor binding ligands in place of their constant region
10/03/1991WO1991014434A1 Multi-functional pharmaceutical compounds and methods of use
10/03/1991WO1991014431A1 Composition and methods for treatment of acne vulgaris and retardation of ageing
10/03/1991WO1991014367A1 Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
10/03/1991WO1991011462A3 Merosin, nucleic acids encoding, fragments and uses thereof
10/03/1991CA2078791A1 Azacyclic or azabicyclic compounds, their preparation and use
10/02/1991EP0449728A1 4H-pyrrolo (1,2-a)thieno(2,3-f)(1,4)diazepine derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/1991EP0449722A1 New complexes of tiaprofenic acid or its insoluble or partially soluble esters with cyclodextrines or their derivates
10/02/1991EP0449562A2 Use of R-Fluoxetine as selective serotonin IC-receptor ligands
10/02/1991EP0449561A2 Use of (R)-norfluoxetine in the preparation of a medicament with affinity to 5HT1c receptors
10/02/1991EP0449346A2 4-Piperidinyl-ergoline derivatives
10/02/1991EP0449301A1 Propanobicyclic amine derivatives for CNS disorders
10/02/1991EP0449247A2 Pharmaceutical composition containing Galanthamine for treating alcoholism
10/02/1991EP0449195A2 Aminobenzene compounds, their production and use
10/02/1991EP0449187A2 Piperidin ether derivatives as psychotropic drugs or plant fungicides
10/02/1991EP0449186A2 N-aralkyl piperidine derivatives as psychotropic drugs
10/02/1991EP0449167A1 Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions
10/02/1991EP0448895A1 Use of a non-alcoholic delivery system for active ingredients which are ingested orally
10/01/1991US5053548 Biphenyl derivative composition for nerve cell degeneration repairing or protective agent and process for preparing a phenyl derivative contained in the composition
10/01/1991US5053521 3-amino butyric acid uptake inhibitors, antiepileptic agents
10/01/1991US5053511 Analgesics; anticonvulsants; treatment for alzheimers disease
10/01/1991US5053430 Use of 2,7-diamino-1,2,3,4-tetrahydronaphthalenes as medicaments, new 2,7-diamino-1,2,3,4-tetrahydronaphthalenes and processes for their preparation
10/01/1991US5053422 Learning-memory enhancers; nootropic agents
10/01/1991US5053419 Administering calcium channel antagonists
10/01/1991US5053416 Alzheimer's disease; central cholinomimetic activity
10/01/1991US5053411 N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
10/01/1991CA2039320A1 Biogenic amine uptake inhibitors
10/01/1991CA1289962C 5-heterocyclic-2,4-dialkyl-3h-1,2,4-triazole-3- thiones and their use as antidepressants
10/01/1991CA1289955C Synthesis of 2-aminopyrimido¬4,5-g|quinolines
10/01/1991CA1289948C 12- and 13-substituted ergoline derivatives
10/01/1991CA1289947C 1-alkyl ergolinylthiourea derivatives, process for the preparation thereof, as well as their use as medicinal agents
09/1991
09/30/1991CA2039398A1 Propanobicyclic amine derivatives for cns disorders
09/30/1991CA2039103A1 Improvements in and relating to the selective occupation of serotonin 1c receptors
09/30/1991CA2039102A1 Compounds affecting serotonin receptors
09/29/1991CA2038692A1 Piperidine ether derivatives as psychotropic drugs or plant fungicides
09/29/1991CA2038681A1 N-aralkyl piperidine derivatives as psychotropic drugs
09/28/1991WO1991014674A2 5-lipoxygenase inhibitors
09/28/1991CA2078126A1 5-lipoxygenase inhibitors
09/28/1991CA2039114A1 4h-pyrrolo[1,2-a]thieno[2,3-f]diazepine[1,4]derivatives, a process for their preparation and pharmaceutical compositions holding same
09/28/1991CA2039055A1 Treatment of sinus headache
09/27/1991CA2038962A1 Aminobenzene compounds, their production and use
09/25/1991EP0448299A2 Composition for increased skin concentration of active agents by iontophoresis
09/25/1991EP0447857A1 A polycyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
09/25/1991EP0447836A2 Amyloid peptide precursor RNA
09/25/1991EP0447727A1 Novel 8-sulfamylmethylene-2-amino tetralins
09/25/1991CN1014060B Method for preparaing ortho-azonaphthalene compound
09/25/1991CN1014058B Process for preparation of 2-pyrrolidone derivative
09/25/1991CA2038908A1 Indole derivatives
09/24/1991US5051524 Substituted propane-phosphinic acid compounds
09/24/1991US5051516 Chemical intermediates for central nervous system active drug s
09/24/1991US5051445 3-amino-propyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
09/24/1991US5051442 3-indolyl thioacetate derivatives and NMDA receptor antagonistic use thereof
09/24/1991US5051430 Analgesics and antiinflammatory agents
09/24/1991US5051424 Piperazine compounds which act as sedatives or antidepressants
09/24/1991US5051412 Compounds which may be used as psychotherapeutics for treatment of depression, obesity and aggression
09/24/1991US5051410 Method and composition for enhancing the release of neurotransmitters
09/24/1991US5051403 Method of treating ischemia-related neuronal damage
09/24/1991US5051263 Controlled-release formulations
09/23/1991CA2038539A1 Method for treating emotional numbness
09/23/1991CA2038509A1 Bu-4164e - a and b, prolyl endopeptidase inhibitors
09/22/1991CA2038748A1 8-sulfamylmethylene-2-amino tetralins
09/21/1991WO1991014679A1 Heterocyclic n-substituted derivatives, their preparation and thepharmaceutical compositions containing them
09/20/1991WO1991014683A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2077995A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2038527A1 Therapeutic agent for ischemic diseases
09/19/1991WO1991013985A1 Leukaemia inhibitory factor
09/19/1991WO1991013887A1 Compound tan-1251, its derivatives, their production and use
09/19/1991WO1991013885A1 1-azabicyclic compounds, processes and pharmaceutical compositons containing them
09/19/1991CA2077672A1 Compound tan-1251, its derivatives, their production and use
09/18/1991EP0447345A2 New Azaspyro [4.5] decane-7,9-dione derivatives
09/18/1991EP0447324A1 2,4-Pyrimidinedione derivatives and medicines containing them
09/18/1991EP0447292A1 4-Aminomethyl-piperidine derivatives, their preparation and therapeutic application
09/18/1991EP0447285A1 Naphthalene derivatives, procedure for their preparation and pharmaceutical compositions containing them
09/18/1991EP0446931A1 Human ciliary neuronotrophic factor, DNA sequence encoding the factor, and production of the factor by recombinant technology
09/18/1991EP0446921A2 Optically active alkylene-dioxybenzene derivatives and their use in therapy
09/18/1991EP0446798A1 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1, 3-propanediols and related compounds, a process and intermediates for their preparation and their use as medicaments
09/18/1991EP0446753A1 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films and their preparation process
09/18/1991EP0446706A2 Peptides with tachykinin-agonistic or -antagonistic activity
1 ... 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 ... 1833